LivaNova (LIA) Stock Forecast & Price Target

4 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

LIA Analyst Ratings

Strong Buy

5 Buy

1 Hold

0 Sell

Based on 6 analysts giving stock ratings to

LivaNova

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

LIA Stock 12 Month Forecast

Average Price Target

€77.05

▲(12.48% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for LivaNova in the last 3 months. The average price target is €77.05 with a high forecast of €82.40 and a low forecast of €70.25. The average price target represents a 12.48% change from the last price of €68.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"35":"€35","47":"€47","59":"€59","71":"€71","83":"€83"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":82.39725725,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€82.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":77.04866335833333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€77.05</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70.25450355,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€70.25</span>\n  </div></div>","useHTML":true}}],"tickPositions":[35,47,59,71,83],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71,71.87671209615385,72.75342419230769,73.63013628846154,74.50684838461538,75.38356048076923,76.26027257692307,77.13698467307692,78.01369676923076,78.89040886538461,79.76712096153845,80.6438330576923,81.52054515384614,{"y":82.39725725,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71,71.46528179679487,71.93056359358974,72.39584539038461,72.86112718717949,73.32640898397436,73.79169078076923,74.2569725775641,74.72225437435897,75.18753617115384,75.65281796794872,76.11809976474359,76.58338156153846,{"y":77.04866335833333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71,70.94265411923077,70.88530823846153,70.8279623576923,70.77061647692308,70.71327059615385,70.65592471538461,70.59857883461538,70.54123295384615,70.48388707307691,70.4265411923077,70.36919531153846,70.31184943076923,{"y":70.25450355,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":36.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.4,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€82.40

Average Price Target€77.05

Lowest Price Target€70.25

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Michael Matson

Needham

€70.25→€80.66

Buy

17.76%

Upside

Reiterated

08/05/26

LivaNova price target raised to $93 from $81 at NeedhamLivaNova price target raised to $93 from $81 at Needham

Rick Wise

Stifel Nicolaus

€69.39→€73.72

Buy

7.63%

Upside

Reiterated

08/05/26

LivaNova price target raised to $85 from $80 at StifelLivaNova price target raised to $85 from $80 at Stifel

Anthony Petrone

Mizuho Securities

€78.06→€82.4

Buy

20.29%

Upside

Reiterated

07/15/26

LivaNova price target raised to $95 from $90 at MizuhoLivaNova price target raised to $95 from $90 at Mizuho

Keith Hinton

Freedom Capital Markets

€70.25

Hold

2.56%

Upside

Initiated

06/30/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: LivaNova (NASDAQ: LIVN), Gain Therapeutics (NASDAQ: GANX) and Tempus AI, Inc. Class A (NASDAQ: TEM)

Adam Maeder

Piper Sandler

€75.46

Buy

10.16%

Upside

Reiterated

06/23/26

Piper Sandler Reaffirms Their Buy Rating on LivaNova (LIVN)

Brett Fishbin

KeyBanc

€71.99→€79.8

Buy

16.49%

Upside

Assigned

06/22/26

LivaNova (LIVN) Gets a Buy from KeyBanc

David Rescott

Robert W. Baird

€67.65→€65.92

Buy

-3.77%

Downside

Reiterated

05/07/26

LivaNova price target lowered to $76 from $78 at BairdLivaNova price target lowered to $76 from $78 at Baird

Matt Miksic

Barclays

€63.32→€65.92

Hold

-3.77%

Downside

Reiterated

05/07/26

Barclays Keeps Their Hold Rating on LivaNova (LIVN)

David Roman

Goldman Sachs

€60.71→€62.45

Hold

-8.83%

Downside

Reiterated

05/06/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Revolution Medicines (NASDAQ: RVMD), LivaNova (NASDAQ: LIVN) and Vir Biotechnology (NASDAQ: VIR)

Matthew Taylor

Jefferies

€68.52→€69.39

Buy

1.30%

Upside

Reiterated

08/07/25

Jefferies Sticks to Their Buy Rating for LivaNova (LIVN)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Michael Matson

Needham

€70.25→€80.66

Buy

17.76%

Upside

Reiterated

08/05/26

LivaNova price target raised to $93 from $81 at NeedhamLivaNova price target raised to $93 from $81 at Needham

Rick Wise

Stifel Nicolaus

€69.39→€73.72

Buy

7.63%

Upside

Reiterated

08/05/26

LivaNova price target raised to $85 from $80 at StifelLivaNova price target raised to $85 from $80 at Stifel

Anthony Petrone

Mizuho Securities

€78.06→€82.4

Buy

20.29%

Upside

Reiterated

07/15/26

LivaNova price target raised to $95 from $90 at MizuhoLivaNova price target raised to $95 from $90 at Mizuho

Keith Hinton

Freedom Capital Markets

€70.25

Hold

2.56%

Upside

Initiated

06/30/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: LivaNova (NASDAQ: LIVN), Gain Therapeutics (NASDAQ: GANX) and Tempus AI, Inc. Class A (NASDAQ: TEM)

Adam Maeder

Piper Sandler

€75.46

Buy

10.16%

Upside

Reiterated

06/23/26

Piper Sandler Reaffirms Their Buy Rating on LivaNova (LIVN)

Brett Fishbin

KeyBanc

€71.99→€79.8

Buy

16.49%

Upside

Assigned

06/22/26

LivaNova (LIVN) Gets a Buy from KeyBanc

David Rescott

Robert W. Baird

€67.65→€65.92

Buy

-3.77%

Downside

Reiterated

05/07/26

LivaNova price target lowered to $76 from $78 at BairdLivaNova price target lowered to $76 from $78 at Baird

Matt Miksic

Barclays

€63.32→€65.92

Hold

-3.77%

Downside

Reiterated

05/07/26

Barclays Keeps Their Hold Rating on LivaNova (LIVN)

David Roman

Goldman Sachs

€60.71→€62.45

Hold

-8.83%

Downside

Reiterated

05/06/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Revolution Medicines (NASDAQ: RVMD), LivaNova (NASDAQ: LIVN) and Vir Biotechnology (NASDAQ: VIR)

Matthew Taylor

Jefferies

€68.52→€69.39

Buy

1.30%

Upside

Reiterated

08/07/25

Jefferies Sticks to Their Buy Rating for LivaNova (LIVN)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering LivaNova

3 Months

David RescottRobert W. Baird

Success Rate

8/11 ratings generated profit

Average Return

+11.87%

Copying David Rescott's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +11.87% per trade.

1 Year

David RescottRobert W. Baird

Success Rate

11/11 ratings generated profit

Average Return

+49.14%

Copying David Rescott's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +49.14% per trade.

2 Years

David RescottRobert W. Baird

Success Rate

11/11 ratings generated profit

Average Return

+73.06%

Copying David Rescott's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +73.06% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LIA Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, LIA has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. LIA average Analyst price target in the past 3 months is 77.05.

Each month's total comprises the sum of three months' worth of ratings.

LIA Financial Forecast

LIA Earnings Forecast

Next quarter’s earnings estimate for LIA is €0.92 with a range of €0.89 to €0.96. The previous quarter’s EPS was €1.09. LIA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.32% of the time in the same period. In the last calendar year LIA has Performed in-line its overall industry.

LIA Sales Forecast

Next quarter’s sales forecast for LIA is €330.18M with a range of €328.06M to €334.81M. The previous quarter’s sales results were €338.98M. LIA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 31.16% of the time in the same period. In the last calendar year LIA has Performed in-line its overall industry.

LIA Stock Forecast FAQ

What is DE:LIA’s average 12-month price target, according to analysts?

Based on analyst ratings, LivaNova PLC’s 12-month average price target is 77.05.

What is DE:LIA’s upside potential, based on the analysts’ average price target?

LivaNova PLC has 12.48% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is LivaNova PLC a Buy, Sell or Hold?

LivaNova PLC has a consensus rating of Strong Buy, which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.

What is LivaNova PLC’s share price target?

The average share price target for LivaNova PLC is 77.05. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €82.40 ,and the lowest forecast is €70.25. The average share price target represents 12.48% Increase from the current price of €68.5.

What do analysts say about LivaNova PLC?

LivaNova PLC’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of LivaNova PLC?

To buy shares of DE:LIA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

LivaNova (LIA) Stock Forecast & Price Target

LIA Analyst Ratings

LIA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering LivaNova

LIA Analyst Recommendation Trends

LIA Financial Forecast

LIA Earnings Forecast

LIA Sales Forecast

LIA Stock Forecast FAQ

Detailed List of Analyst Forecasts